Trials / Conditions / HPV-Related Malignancy

HPV-Related Malignancy

16 registered clinical trials studyying HPV-Related Malignancy — 8 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers NCT05639972	Christian Hinrichs	Phase 1 / Phase 2
Recruiting	PRGN-2009 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Recurrent or Metastatic Cerv NCT06157151	Precigen, Inc	Phase 2
Recruiting	Feasibility of HPV Testing With Mail-delivered Sample Collection Kits NCT07087145	University of California, San Francisco	—
Active Not Recruiting	A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) NCT05973487	TScan Therapeutics, Inc.	Phase 1
Withdrawn	Efficacy and Safety of VB10.16 Alone or in Combination With Atezolizumab in Patients With Advanced Cervical Ca NCT06099418	Nykode Therapeutics ASA	Phase 2
Recruiting	SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas NCT06544720	The Affiliated Hospital of Qingdao University	Phase 1
Recruiting	Prognostic Value of Conization and Negative HPV After Conization in AIS and Early Stage Cervical Cancer NCT06196190	Rambam Health Care Campus	—
Completed	Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC NCT05510908	AIDS Malignancy Consortium	—
Recruiting	E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers NCT05686226	Christian Hinrichs	Phase 2
Recruiting	A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With H NCT05307939	Memorial Sloan Kettering Cancer Center	Phase 2
Recruiting	The Organ Transplant Recipient HPV and Skin Cancer Study NCT05284877	Merete Haedersdal	—
Terminated	This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Sele NCT05061940	Repertoire Immune Medicines	—
Completed	Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial NCT04679675	Kaiser Permanente	N/A
Completed	IPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell Carcinoma NCT03795610	Assuntina G. Sacco, MD	Phase 2
Completed	Postpartum HPV Vaccination NCT03451071	University of Alabama at Birmingham	Phase 4
Completed	HPV in Blood Samples From Cervical Cancer Patients. NCT03749720	University of Aarhus	N/A